Cryopreservation – Products

TRANSCAN-3 advances personalized T-cell therapies for esophageal cancer with progress in neoantigen discovery and T-cell isolation.

InSphero acquires DOPPL SA and Sun Bioscience’s Gri3D^® platform, expanding its unified 3D spheroid–organoid ecosystem for scalable drug discovery.

CELLBANKER® offers safer, consistent cryopreservation compared to homebrew media, ensuring better post-thaw viability.

Thermo Fisher launches Olink Target 48 Neurodegeneration panel to measure 41 protein biomarkers for brain disease research.

This case study shows how a next-generation pTau 217 assay achieves higher accuracy than existing platforms using only 1 µL of diluted plasma, while maintaining robust performance across freeze-thawed samples and diverse cohorts.

Linkam showcases cryogenic and heating stages at M&M 2025 – including new infrared and cryo-plunge systems.

Ultima’s UG 100 platform will support proteomics studies analyzing 800,000 samples across the U.S. and UK.

Brenus Pharma and InSphero presented at EACR 2025 data confirming that 3D tumor spheroids are an effective model for testing STC1010 in colorectal cancer.

Objective Biotechnology’s Autoinjector, validated in a GENETICS study, automates the microinjection process, speeding up experiments while maintaining high precision.

The large-scale study aims to create a comprehensive map of the human proteome to monitor changes reflecting human health and disease.